- Projects & figures
- News & Events
- Managing your project
- About ERC
Diseases affecting the retina cause one quarter of worldwide blindness. To date, there are no treatments to restore lost retinal cells and visual function, making it urgent to find new therapeutic approaches. Can stem cells be the solution? Prof. Majlinda Lako aims at growing artificial replicas of the human retina using stem cells.
Every day thousands of people across Europe are working together to keep EU citizens safe from challenges to do with health, the environment, crime, terrorism, migration and the economy.
Key nutrients can improve vision both in ageing and in healthy eyes, according to EU-funded research. Doctors are now prescribing supplements of these nutrients, while the researchers are investigating other possible health benefits.
A project funded by the ERC developed an innovative and comprehensive framework to study energy poverty in Europe. It also produced evidence applicable beyond academia, laying ground for the EU’s Energy Poverty Observatory set up in 2018.
Cities and regions around the world are increasingly inter-connected. One clear factor for this connectivity is foreign investment: the flow of capital, skills and knowledge that can – under the right circumstances - "bless" an area, improving its economic and social standing. ERC grantee Riccardo Crescenzi studies where these flows are concentrated, how different actors choose where to invest and what are their impacts on both the home and host economies.
An EU-funded project is exploring what keeps people committed to a task even when they get bored, distracted or are tempted to stop. The findings could foster productivity-boosting strategies, improve robot-human interactions and even help treat borderline personality disorder.
Teaching is certainly one of the most important professions in our society, yet its status and attractiveness have been systematically diminishing in the last decades. At the Université catholique de Louvain, Prof. Xavier Dumay is using his ERC Starting Grant to investigate the cultural and institutional transformations that have led to this "teaching profession crisis".
At the forefront of medicine, gene therapy is based on the insertion of genes into an individual's cells and tissues to treat a disease. Scientists are currently testing several approaches to this experimental technique. One of them, Prof. Seppo Ylä-Herttuala, intends to develop a novel method to treat myocardial ischemia by activating endogenous genes to propel angiogenesis. If successful, he will open a new era in gene therapy.
More than 100 million people worldwide suffer from valvular heart disease, affecting one or more of the heart’s four valves and causing breathlessness, chest pain, dizziness and fainting. If severe valvular heart disease is not properly treated, chances of surviving decrease, especially in the elderly. The only effective therapy is heart valve replacement, which may entail some risks and lead to revision surgeries. What can be done to improve safety and durability of artificial heart valves?
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. European researchers developed novel ex vivo three-dimensional organoid cultures that replicate genetic events in CRC, as tools to test novel therapeutics.